List of directors and their roles and functions
Filed with HKEX · Stock code 1952 · · 1 page · English
Summary by 6ix AI
This filing is a list of directors and their roles for Everest Medicines Ltd.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Everest Medicines
- Establishment of environmental, social and governance committee
- Next Day Disclosure Return
- Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults
- Everest Medicines Announces Interim Results for First Half of 2026
- Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026
Later from Everest Medicines
- Terms of reference of the environmental, social and governance committee
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
- Book closure period for extraordinary general meeting
- (1) Continuing connected transactions in relation to the strategic cooperation framework agreement; and (2) notice of extraordinary general meeting
Follow Everest Medicines into a list and get an email when it puts out news.
Follow Everest Medicines